| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |